Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient’s life expectancy, the emphasis is on improving overall quality of life.
With growing prevalence of cancer, the demand for cancer treatments, such as chemotherapy has also been consistently on the rise since the past decade. However, radiation therapy brings with it a host of side effects that are challenging for cancer patients to face while they undergo the course of treatment. While the cancer treatment realm is tremendously progressing, the incidences of side effects are increasing as well, which are addressed by cancer supportive care. The advent of technology in cancer supportive care has enabled to treat different signs and symptoms following the chemotherapy procedure, in addition to chemotherapy-induced vomiting, nausea, neutropenia, and anemia. The global market for cancer supportive care products is currently thriving at a sound pace and is anticipated to see steady growth over the next few years.The high investment in the oncology segment and pharmaceutical industry in US and Canada, and the presence of several large vendors operating in US contribute to the growth of the palliative cancer care market in the Americas. Additionally, constant R&D activities in the oncology sector, strong economic condition, and huge investments in the healthcare segment further contribute to the market growth.
The report details the trend, potential and market size of Cancer Supportive Care market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Supportive Caremarket, defines the market attractiveness level of Cancer Supportive Care market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cancer Supportive Care industry, describes the types of Cancer Supportive Care market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Supportive Care market and the development prospects and opportunities of Cancer Supportive Care industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Supportive Care market in Chapter 13.
By Player:
Johnson &Johnson
F Hoffmann-La Roche
Amgen
GlaxoSmithKline
Novartis
Merck
Helsinn Healthcare
TESARO
Teva Pharmaceutical Industries
By Type:
Nonsteroidal Erythropoietin Stimulating Agents
Opioid Analgesics
Anti-Imflammatory Drugs
Anti-Infective Drugs
Bisphosphonates
Anti-Emetics Drugs
Monoclonal Antibodies
Granulocyte Colony Stimulating Factor
By End-User:
Lung Cancer
Breast Cancer
Prostate Cancer
Liver Cancer
Bladder Cancer
Leukemia
Ovarian Cancer
Melanoma
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cancer Supportive Care Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cancer Supportive Care Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cancer Supportive Care Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cancer Supportive Care Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cancer Supportive Care Market Analysis and Outlook to 2022
-
7.1 Global Cancer Supportive Care Consumption (2017-2022)
-
7.2 United States Cancer Supportive Care Consumption (2017-2022)
-
7.3 Europe Cancer Supportive Care Consumption (2017-2022)
-
7.4 China Cancer Supportive Care Consumption (2017-2022)
-
7.5 Japan Cancer Supportive Care Consumption (2017-2022)
-
7.6 India Cancer Supportive Care Consumption (2017-2022)
-
7.7 South Korea Cancer Supportive Care Consumption (2017-2022)
8 Region and Country-wise Cancer Supportive Care Market Analysis and Outlook to 2028
-
8.1 Global Cancer Supportive Care Consumption Forecast (2022-2028)
-
8.2 United States Cancer Supportive Care Consumption Forecast (2022-2028)
-
8.3 Europe Cancer Supportive Care Consumption Forecast (2022-2028)
-
8.4 China Cancer Supportive Care Consumption Forecast (2022-2028)
-
8.5 Japan Cancer Supportive Care Consumption Forecast (2022-2028)
-
8.6 India Cancer Supportive Care Consumption Forecast (2022-2028)
-
8.7 South Korea Cancer Supportive Care Consumption Forecast (2022-2028)
9 Global Cancer Supportive Care Market Outlook by Types and Applications to 2022
-
9.1 Global Cancer Supportive Care Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Nonsteroidal Erythropoietin Stimulating Agents Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Opioid Analgesics Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Anti-Imflammatory Drugs Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Anti-Infective Drugs Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Bisphosphonates Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Anti-Emetics Drugs Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Granulocyte Colony Stimulating Factor Consumption and Growth Rate (2017-2022)
-
9.2 Global Cancer Supportive Care Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Liver Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Bladder Cancer Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Leukemia Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
9.2.8 Global Melanoma Consumption and Growth Rate (2017-2022)
-
9.2.9 Global Others Consumption and Growth Rate (2017-2022)
10 Global Cancer Supportive Care Market Outlook by Types and Applications to 2028
-
10.1 Global Cancer Supportive Care Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Nonsteroidal Erythropoietin Stimulating Agents Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Opioid Analgesics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Anti-Imflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Anti-Infective Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Bisphosphonates Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Anti-Emetics Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.8 Global Granulocyte Colony Stimulating Factor Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cancer Supportive Care Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Liver Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Bladder Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Leukemia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.7 Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.8 Global Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.9 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Cancer Supportive Care Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cancer Supportive Care Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cancer Supportive Care Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cancer Supportive Care Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cancer Supportive Care Market Competitive Analysis
-
14.1 Johnson &Johnson
-
14.1.1 Johnson &Johnson Company Details
-
14.1.2 Johnson &Johnson Cancer Supportive Care Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Johnson &Johnson Cancer Supportive Care Product and Service
-
14.2 F Hoffmann-La Roche
-
14.2.1 F Hoffmann-La Roche Company Details
-
14.2.2 F Hoffmann-La Roche Cancer Supportive Care Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 F Hoffmann-La Roche Cancer Supportive Care Product and Service
-
14.3 Amgen
-
14.3.1 Amgen Company Details
-
14.3.2 Amgen Cancer Supportive Care Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Amgen Cancer Supportive Care Product and Service
-
14.4 GlaxoSmithKline
-
14.4.1 GlaxoSmithKline Company Details
-
14.4.2 GlaxoSmithKline Cancer Supportive Care Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GlaxoSmithKline Cancer Supportive Care Product and Service
-
14.5 Novartis
-
14.5.1 Novartis Company Details
-
14.5.2 Novartis Cancer Supportive Care Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis Cancer Supportive Care Product and Service
-
14.6 Merck
-
14.6.1 Merck Company Details
-
14.6.2 Merck Cancer Supportive Care Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Merck Cancer Supportive Care Product and Service
-
14.7 Helsinn Healthcare
-
14.7.1 Helsinn Healthcare Company Details
-
14.7.2 Helsinn Healthcare Cancer Supportive Care Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Helsinn Healthcare Cancer Supportive Care Product and Service
-
14.8 TESARO
-
14.8.1 TESARO Company Details
-
14.8.2 TESARO Cancer Supportive Care Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 TESARO Cancer Supportive Care Product and Service
-
14.9 Teva Pharmaceutical Industries
-
14.9.1 Teva Pharmaceutical Industries Company Details
-
14.9.2 Teva Pharmaceutical Industries Cancer Supportive Care Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Teva Pharmaceutical Industries Cancer Supportive Care Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cancer Supportive Care
-
Figure Cancer Supportive Care Picture
-
Table Global Cancer Supportive Care Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Supportive Care Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Supportive Care Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cancer Supportive Care Consumption by Country (2017-2022)
-
Figure United States Cancer Supportive Care Consumption and Growth Rate (2017-2022)
-
Table Europe Cancer Supportive Care Consumption and Growth Rate (2017-2022)
-
Figure China Cancer Supportive Care Consumption and Growth Rate (2017-2022)
-
Figure Japan Cancer Supportive Care Consumption and Growth Rate (2017-2022)
-
Figure India Cancer Supportive Care Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cancer Supportive Care Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Supportive Care Consumption Forecast by Country (2022-2028)
-
Figure United States Cancer Supportive Care Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cancer Supportive Care Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cancer Supportive Care Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cancer Supportive Care Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cancer Supportive Care Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cancer Supportive Care Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nonsteroidal Erythropoietin Stimulating Agents Consumption and Growth Rate (2017-2022)
-
Figure Global Opioid Analgesics Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-Imflammatory Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-Infective Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Bisphosphonates Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-Emetics Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Granulocyte Colony Stimulating Factor Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Liver Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Bladder Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Leukemia Consumption and Growth Rate (2017-2022)
-
Figure Global Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Melanoma Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Nonsteroidal Erythropoietin Stimulating Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Opioid Analgesics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-Imflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-Infective Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bisphosphonates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-Emetics Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Granulocyte Colony Stimulating Factor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liver Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bladder Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Leukemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cancer Supportive Care Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cancer Supportive Care Export by Region (Top 5 Countries) (2017-2028)
-
Table Johnson &Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson &Johnson Cancer Supportive Care Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson &Johnson Cancer Supportive Care Product and Service
-
Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Cancer Supportive Care Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Cancer Supportive Care Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Cancer Supportive Care Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Cancer Supportive Care Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Cancer Supportive Care Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Cancer Supportive Care Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Cancer Supportive Care Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Cancer Supportive Care Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Cancer Supportive Care Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Cancer Supportive Care Product and Service
-
Table Helsinn Healthcare (Foundation Year, Company Profile and etc.)
-
Table Helsinn Healthcare Cancer Supportive Care Sales, Price, Value and Gross Profit (2017-2022)
-
Table Helsinn Healthcare Cancer Supportive Care Product and Service
-
Table TESARO (Foundation Year, Company Profile and etc.)
-
Table TESARO Cancer Supportive Care Sales, Price, Value and Gross Profit (2017-2022)
-
Table TESARO Cancer Supportive Care Product and Service
-
Table Teva Pharmaceutical Industries (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Cancer Supportive Care Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Cancer Supportive Care Product and Service
-
